Rafael Grochot

Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial

Susana Banerjee, Matthew Krebs, Alastair Greystoke et al. · Nature Medicine · 2025 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity

Daniel Westaby, Juan M. Jiménez‐Vacas, Ines Figueiredo et al. · Journal of Clinical Investigation · 2024 · 23 citations · Full text

Medicine, Molecular Biology, Oncology +17

<p>Expression of PD-L1 in cervical carcinoma and its impact on survival associated with T-cell infiltration and FoxP3 expression</p>

Rafael Grochot, Janaína Brollo, Floriano Riva Neto et al. · Cancer Management and Research · 2019 · 22 citations · Full text

Medicine, Oncology, Pathology +17

725MO Phase I study of the combination of the dual RAF/MEK inhibitor VS-6766 and the FAK inhibitor defactinib: Results of efficacy in low grade serous ovarian cancer

Susana Banerjee, Rafael Grochot, R. Shinde et al. · Annals of Oncology · 2021 · 18 citations

Medicine, Oncology, Pharmacology +16